Bongoni Anjan K, Lu Bo, McRae Jennifer L, Salvaris Evelyn J, Toonen Erik J M, Vikstrom Ingela, Baz Morelli Adriana, Pearse Martin J, Cowan Peter J
Immunology Research Centre, St. Vincent's Hospital, Melbourne, Australia.
R&D Department, Hycult Biotech, Uden, The Netherlands.
Transplant Direct. 2019 Mar 25;5(4):e341. doi: 10.1097/TXD.0000000000000881. eCollection 2019 Apr.
Complement activation plays an important role in the pathogenesis of renal ischemia-reperfusion (IR) injury (IRI), but whether this involves damage to the vasculoprotective endothelial glycocalyx is not clear. We investigated the impact of complement activation on glycocalyx integrity and renal dysfunction in a mouse model of renal IRI.
Right nephrectomized male C57BL/6 mice were subjected to 22 minutes left renal ischemia and sacrificed 24 hours after reperfusion to analyze renal function, complement activation, glycocalyx damage, endothelial cell activation, inflammation, and infiltration of neutrophils and macrophages.
Ischemia-reperfusion induced severe renal injury, manifested by significantly increased serum creatinine and urea, complement activation and deposition, loss of glycocalyx, endothelial activation, inflammation, and innate cell infiltration. Treatment with the anti-C5 antibody BB5.1 protected against IRI as indicated by significantly lower serum creatinine ( = 0.04) and urea ( = 0.003), tissue C3b/c and C9 deposition (both = 0.004), plasma C3b ( = 0.001) and C5a ( = 0.006), endothelial vascular cell adhesion molecule-1 expression ( = 0.003), glycocalyx shedding (tissue heparan sulfate [ = 0.001], plasma syndecan-1 [ = 0.007], and hyaluronan [ = 0.02]), inflammation (high mobility group box-1 [ = 0.0003]), and tissue neutrophil ( = 0.0009) and macrophage ( = 0.004) infiltration.
Together, our data confirm that the terminal pathway of complement activation plays a key role in renal IRI and demonstrate that the mechanism of injury involves shedding of the glycocalyx.
补体激活在肾缺血再灌注(IR)损伤(IRI)的发病机制中起重要作用,但这是否涉及对血管保护内皮糖萼的损伤尚不清楚。我们在肾IRI小鼠模型中研究了补体激活对糖萼完整性和肾功能障碍的影响。
对右肾切除的雄性C57BL/6小鼠进行22分钟的左肾缺血,并在再灌注后24小时处死,以分析肾功能、补体激活、糖萼损伤、内皮细胞激活、炎症以及中性粒细胞和巨噬细胞浸润情况。
缺血再灌注诱导了严重的肾损伤,表现为血清肌酐和尿素显著升高、补体激活和沉积、糖萼丢失、内皮激活、炎症以及固有细胞浸润。用抗C5抗体BB5.1治疗可预防IRI,表现为血清肌酐(P = 0.04)和尿素(P = 0.003)显著降低、组织C3b/c和C9沉积(均为P = 0.004)、血浆C3b(P = 0.001)和C5a(P = 0.006)、内皮血管细胞黏附分子-1表达(P = 0.003)、糖萼脱落(组织硫酸乙酰肝素[P = 0.001]、血浆多配体蛋白聚糖-1[P = 0.007]和透明质酸[P = 0.02])、炎症(高迁移率族蛋白B1[P = 0.0003])以及组织中性粒细胞(P = 0.0009)和巨噬细胞(P = 0.004)浸润减少。
总之,我们的数据证实补体激活的终末途径在肾IRI中起关键作用,并表明损伤机制涉及糖萼脱落。